{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:08:16Z","timestamp":1773335296888,"version":"3.50.1"},"reference-count":50,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a leading cause of euvolaemic hyponatraemia and remains challenging to manage due to limitations of existing therapies, including poor adherence to fluid restriction and safety concerns associated with vasopressin receptor antagonists and demeclocycline. Recent mechanistic and clinical evidence suggests that sodium\u2013glucose cotransporter-2 (SGLT2) inhibitors may offer a novel therapeutic approach by promoting osmotic diuresis and increasing electrolyte-free water clearance. This narrative review synthesises current pathophysiological understanding and emerging clinical evidence regarding the role of SGLT2 inhibitors in SIADH-related hyponatraemia. We examine how their proximal tubular mechanism differs from conventional therapies such as loop diuretics, vaptans, and salt supplementation, and evaluate evidence from recent randomised and crossover trials demonstrating improved serum sodium and enhanced water excretion with empagliflozin and dapagliflozin. SGLT2 inhibitors represent a physiologically rational and potentially safer alternative in selected patients with SIADH, particularly where fluid restriction is poorly tolerated or ineffective. Although further large-scale studies are required to define their optimal positioning within treatment algorithms, current evidence supports their potential role as an emerging therapeutic option in SIADH management.<\/jats:p>","DOI":"10.3390\/jcm15062119","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:04:24Z","timestamp":1773162264000},"page":"2119","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SGLT2 Inhibitors as a Novel Therapeutic Strategy in SIADH-Induced Hyponatraemia: Emerging Evidence and Clinical Implications"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5062-8020","authenticated-orcid":false,"given":"Neena","family":"Kamran","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Mid Yorkshire Teaching NHS Trust, Wakefield WF1 4DG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misbah","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Mid Yorkshire Teaching NHS Trust, Wakefield WF1 4DG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"170","author":"Spasovski","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: Expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"The syndrome of inappropriate antidiuresis","volume":"356","author":"Ellison","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra1404489","article-title":"Disorders of plasma sodium","volume":"372","author":"Sterns","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1681\/ASN.2016101139","article-title":"Diagnosis and treatment of hyponatremia: Compilation of the guidelines","volume":"28","author":"Hoorn","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Madias","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.amjmed.2006.05.005","article-title":"Incidence and prevalence of hyponatremia","volume":"119","author":"Upadhyay","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.amjmed.2009.01.027","article-title":"Mortality after hospitalization with hyponatremia","volume":"122","author":"Waikar","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"71.e1","DOI":"10.1016\/j.amjmed.2005.09.026","article-title":"Mild chronic hyponatremia and falls","volume":"119","author":"Renneboog","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_10","first-page":"383","article-title":"Clinical consequences of hyponatremia","volume":"52","author":"Corona","year":"2016","journal-title":"Endocrine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/qjmed\/hcl071","article-title":"Severe hyponatremia in medical inpatients","volume":"99","author":"Clayton","year":"2006","journal-title":"QJM"},{"key":"ref_12","first-page":"F59","article-title":"Regulation of vasopressin secretion","volume":"233","author":"Robertson","year":"1977","journal-title":"Am. J. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","article-title":"Aquaporins in the kidney","volume":"82","author":"Nielsen","year":"2002","journal-title":"Physiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMra1404726","article-title":"Molecular physiology of water balance","volume":"372","author":"Knepper","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2007091042","article-title":"Impact of solute intake on urine flow","volume":"19","author":"Berl","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amjmed.2010.01.013","article-title":"Diagnostic approach to hyponatremia","volume":"123","author":"Fenske","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.neuroscience.2010.03.042","article-title":"Brain adaptation to hyponatremia","volume":"168","author":"Verbalis","year":"2010","journal-title":"Neuroscience"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1001\/jama.281.24.2299","article-title":"Neurological complications","volume":"281","author":"Ayus","year":"1999","journal-title":"JAMA"},{"key":"ref_19","first-page":"319","article-title":"Drug-induced hyponatremia","volume":"39","author":"Filippatos","year":"2016","journal-title":"Drug Saf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semnephrol.2009.03.008","article-title":"Urinary concentration physiology","volume":"29","author":"Sands","year":"2009","journal-title":"Semin. Nephrol."},{"key":"ref_21","first-page":"1078","article-title":"Pathogenesis of SIADH","volume":"49","author":"Verbalis","year":"1996","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","article-title":"Renal effects of SGLT2 inhibition","volume":"60","author":"Vallon","year":"2017","journal-title":"Diabetologia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneph.2016.170","article-title":"Renal effects of SGLT2 inhibitors","volume":"13","author":"DeFronzo","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_24","first-page":"909","article-title":"Renal physiology and SGLT2 inhibition","volume":"86","author":"Cherney","year":"2014","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Clinical effects of SGLT2 inhibitors","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"ref_26","first-page":"133","article-title":"Renal sodium handling with SGLT2 inhibition","volume":"59","author":"Muskiet","year":"2016","journal-title":"Diabetologia"},{"key":"ref_27","first-page":"7815690","article-title":"Empagliflozin mechanistic study","volume":"2017","author":"Refardt","year":"2017","journal-title":"Int. J. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2019090944","article-title":"Empagliflozin randomized trial","volume":"31","author":"Refardt","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1681\/ASN.2022050623","article-title":"Empagliflozin crossover trial","volume":"34","author":"Refardt","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan in hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_31","first-page":"2222","article-title":"Long-term safety of tolvaptan","volume":"22","author":"Verbalis","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","article-title":"Vasopressin receptor antagonists","volume":"371","author":"Decaux","year":"2008","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2215\/CJN.06990711","article-title":"Urea treatment in SIADH","volume":"7","author":"Soupart","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_34","first-page":"813","article-title":"Salt tablets and furosemide","volume":"74","author":"Greenberg","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/eci.12465","article-title":"Diagnosis and management of SIADH","volume":"45","author":"Grant","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_36","first-page":"1133","article-title":"SIADH clinical review","volume":"95","author":"Peri","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1530\/EJE-09-1057","article-title":"SIADH management review","volume":"162","author":"Sherlock","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_38","first-page":"302","article-title":"Hyponatremia review","volume":"12","author":"Liamis","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_39","first-page":"337","article-title":"SIADH treatment options","volume":"5","author":"Zietse","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_40","first-page":"915","article-title":"Clinical approach to hyponatremia","volume":"5","author":"Berl","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA-REG trial","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"CANVAS trial","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"DAPA-HF trial","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"EMPEROR trial","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"DAPA-CKD trial","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic ketoacidosis","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_47","first-page":"473","article-title":"Safety review SGLT2 inhibitors","volume":"40","author":"Goldenberg","year":"2016","journal-title":"Can. J. Diabetes"},{"key":"ref_48","first-page":"761","article-title":"SGLT2 inhibitor mechanisms","volume":"16","author":"Heerspink","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/endrev\/bnad010","article-title":"Contemporary SIADH review","volume":"44","author":"Warren","year":"2023","journal-title":"Endocr. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effects SGLT2 inhibitors","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:32:17Z","timestamp":1773293537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15062119"],"URL":"https:\/\/doi.org\/10.3390\/jcm15062119","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]}}}